Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Genetic Screens02:46

Genetic Screens

5.6K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Zika virus surveillance post-epidemic in blood donors from São Paulo, Brazil 2016-2020.

Transfusion medicine (Oxford, England)·2025
Same author

Prevalence of tonsillar human papillomavirus infection in low-risk individuals without cancer.

Einstein (Sao Paulo, Brazil)·2025
Same author

Long-term chronic infection of a young immunocompromised patient by the SARS-CoV-2 P.2 VOI.

Revista do Instituto de Medicina Tropical de Sao Paulo·2024
Same author

A prospective, multi-centric study on the prevalence of dengue, zika and chikungunya in asymptomatic blood donors from different geographical regions of Brazil.

Transfusion medicine (Oxford, England)·2024
Same author

Intranasal Liposomal Formulation of Spike Protein Adjuvanted with CpG Protects and Boosts Heterologous Immunity of hACE2 Transgenic Mice to SARS-CoV-2 Infection.

Vaccines·2023
Same author

Occult and active hepatitis B virus detection in donated blood in São Paulo, Brazil.

Transfusion·2021

相关实验视频

Updated: Jan 16, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

11.1K

对于宫癌的分子查.

Toni Ricardo Martins1,2, José Eduardo Levi3

  • 1Programa de Pós Graduação em Imunologia Básica e Aplicada-PPGIBA, Universidade Federal do Amazonas, Manaus 14040-903, Brazil.

Genes
|September 27, 2025
PubMed
概括
此摘要是机器生成的。

人类乳头瘤病毒 (HPV) DNA测试正在取代宫癌查的帕普测试,因为它的高灵敏度. 这种转变需要新的策略来管理增加的查阳性病例.

关键词:
宫癌:子宫癌是一种癌症.人类乳头瘤病毒人类乳头瘤病毒查检查 查检查 查检查 查检查

更多相关视频

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

28.1K
In Vivo CRISPR/Cas9 Screening to Simultaneously Evaluate Gene Function in Mouse Skin and Oral Cavity
07:52

In Vivo CRISPR/Cas9 Screening to Simultaneously Evaluate Gene Function in Mouse Skin and Oral Cavity

Published on: November 2, 2020

7.0K

相关实验视频

Last Updated: Jan 16, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

11.1K
RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

28.1K
In Vivo CRISPR/Cas9 Screening to Simultaneously Evaluate Gene Function in Mouse Skin and Oral Cavity
07:52

In Vivo CRISPR/Cas9 Screening to Simultaneously Evaluate Gene Function in Mouse Skin and Oral Cavity

Published on: November 2, 2020

7.0K

科学领域:

  • 在瘤学瘤学.
  • 分子诊断学 分子诊断学
  • 公共卫生 公共卫生

背景情况:

  • 子宫癌 (CC) 是女性普遍发生的新生病.
  • 宫性阴道细胞学 (Pap检测) 是标准的查方法.
  • 人类乳头瘤病毒 (HPV) 确实与宫癌的病因有关.

研究的目的:

  • 审查目前的宫癌查策略.
  • 在宫癌检测中将分子测试置于背景中.
  • 评估从帕普检测到HPV检测的过渡.

主要方法:

  • 关于分子查工具的讨论.
  • 分析各种分子标记物的优缺点.
  • 审查当前的HPV检测协议.

主要成果:

  • 瘤性HPVDNA测试是主要的分子查策略,取代了宫性阴道细胞学.
  • HPV DNA 是检测宫癌和前体病变的最敏感的标记物.
  • 由于HPV测试导致查阳性个体增加,因此对分拣资源的需求增加.

结论:

  • HPV DNA 测试为宫癌的检测提供了更高的灵敏度.
  • HPV 检测的增加需要先进的分拣和基于风险的管理策略.
  • 新算法和技术的持续开发旨在优化查结果.